RandiJenssenHagermanMD

Pediatrics • Davis, CA

Developmental-Behavioral Pediatrics

Professor, Pediatrics, University of California, Davis, School of Medicine

Join to view full profile

Dr. Hagerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hagerman's full profile

Already have an account?

Office
4307 Redbud Pl
Davis, CA 95618
Phone+1 530-750-2141

Fax+1 916-703-0240

Education & Training

University of California (San Diego) Medical CenterFellowship, Developmental-Behavioral Pediatrics, 1978 - 1980
University of California (San Diego) Medical CenterResidency, Pediatrics, 1978 - 1979
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1975 - 1977
Stanford University School of MedicineClass of 1975

Certifications & Licensure

CA State Medical License 2001 - 2026
CO State Medical License 1980 - 2025
WY State Medical License 1993 - 2001
American Board of Pediatrics Pediatrics
American Board of Pediatrics Developmental-Behavioral Pediatrics

Clinical Trials

Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome Start of enrollment: 2007 Sep 01
Completed
Not Applicable
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
Completed
Phase 2
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
Completed
Trial of Minocycline to Treat Children With Fragile X Syndrome Start of enrollment: 2010 Jan 01
Completed
Not Applicable
Trial of Sertraline to Treat Children With Fragile X Syndrome Start of enrollment: 2012 Jan 01
Completed
Phase 2
Ganaxolone Treatment in Children With Fragile X Syndrome Start of enrollment: 2012 Nov 01
Completed
Phase 2
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome Start of enrollment: 2016 Jan 01
Completed
Phase 4
A Trial of Metformin in Individuals With Fragile X Syndrome Start of enrollment: 2018 Apr 30
Completed
Phase 2, Phase 3
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS Start of enrollment: 2021 Jun 25
Completed
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

375 citations
The fragile-X premutation: a maturing perspective.
Paul J. Hagerman, Randi J Hagerman
American Journal of Human Genetics. 2004-05-01
52 citations
Developmental Implications of Changing Trajectories of IQ in Males with Fragile X Syndrome
Robert M. Hodapp, Elisabeth M. Dykens, Randi J Hagerman, Rebecca A. Schreiner, Ave M. Lachiewicz
Journal of the American Academy of Child and Adolescent Psychiatry. 1990-03-01
47 citations
Chromosome fragility and psychopathology in obligate female carriers of the fragile X chromosome
Lisa S. Freund, Allan L. Reiss, Randi J Hagerman, Sophia Vinogradov
Archives of General Psychiatry. 1992-01-01

Journal Articles

Rare FMR1 Gene Mutations Causing Fragile X Syndrome: A Review
Merlin G Butler, Randi J Hagerman, Adam F Sitzmann, American Journal of Medical Genetics Part A

Press Mentions

'Small Data' Goes a Long Way in Rare Disease ResearchFebruary 28th, 2022
Finding a Path Forward for Fragile X DrugsSeptember 23rd, 2021
MIND Institute Brain Bank Focused on Autism, Diversity, Education and ResearchJune 8th, 2021
Join now to see all

Grant Support

Genotype-Phenotype Relationships In Fragile X FamiliesEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2012
Characterization And Treatment Of CNS Abnormalities In Premutation Carriers (4 OfNational Institute On Aging2007–2011
Fragile X Syndrome Cascade Testing And Genetic Counseling ProtocolsCenters For Disease Control And Prevention2005
Genotype-Phenotype Relationship In Fragile XNational Center For Research Resources2004
Action Tremor And Cognitive Functioning In MALE Carriers Of Fragile X SyndromeNational Center For Research Resources2004
Melatonin &Sleep Studies In Children W/ Developmental DisabilitiesNational Center For Research Resources1999–2002
Genotype/ Phenotype Relationships In Fragile X FamiliesNational Center For Research Resources1999–2002
Genotype/Phenotype Relationships In Fragile X FamiliesEunice Kennedy Shriver National Institute Of Child Health &Human Development1999–2000
Geneotype/Phenotype Relationships In Fragile X FamiliesEunice Kennedy Shriver National Institute Of Child Health &Human Development1998
Neurocognitive, Emotional, And Physical Phenotypes Of Fragile X FemalesNational Center For Research Resources1996
Evaluation And Treatment Of Children With Fetal Alcohol SyndromeNational Center For Research Resources1993–1995
Neurocognitive, Emotional And Physical Phenotypes Of Fragile X FemalesNational Center For Research Resources1991–1995
Neurocog, Emot, And Phys Phenotype Of Fragile X FemalesNational Institute Of Mental Health1994
Fourth International Fragile X ConferenceEunice Kennedy Shriver National Institute Of Child Health &Human Development1994
Neurocog, Emot, &Phys Phenotype Of Fragile X FemalesNational Institute Of Mental Health1990–1993
Third International Fragile X ConferenceEunice Kennedy Shriver National Institute Of Child Health &Human Development1992
Seizures And EEG Abnormalties In Fragile X SyndromeNational Center For Research Resources1991–1992

Professional Memberships

American Psychiatric Association - APA
Member